Found 12 matching trials
Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
PHASE1This is a Phase I, randomized, double-blind, placebo-controlled clinical st...
Location
Makerere University Walter Reed Project (MUWRP)
Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults
PHASE1This study will evaluate the safety and tolerability (including reactogenic...
Location
Walter Reed Army Institute of Research, Clinical Trials Center
HIV Vaccine in HIV-uninfected Adults
PHASE1The purpose of this study is to test whether delayed boosting (an extra adm...
Location
Armed Forces Research Institute of Medical Sciences
Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission
PHASE1This is a phase I, randomized, open-label trial to investigate the safety o...
Location
Thai Red Cross AIDS Research Centre (TRCARC)
A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy Adults
PHASE1A Phase 1, open label clinical study to evaluate the safety, immunogenicity...
Location
WRAIR, Clinical Trials Center
A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy Adults
PHASE1A Phase 1, open label clinical study to evaluate the safety, immunogenicity...
Location
Walter Reed Army Institute of Research
Safety and Immunogenicity of CJCV2 With and Without ALFQ
PHASE1This is a randomized, double-blind, dose-escalating, outpatient trial in a ...
Location
Cincinnati Children's Hospital Medical Center Vaccine Research Center
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
PHASE1This is a phase I, randomized, double-blind, placebo-controlled clinical tr...
Location
The Faculty of Medicine, Chulalongkorn University/ King Chulalongkorn Memorial Hospital
Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults
PHASE1Background:
Influenza (flu) is a contagious respiratory illness caused by ...
Location
National Institutes of Health Clinical Center
PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19
PHASE1The purpose of this study is to evaluate the safety, reactogenicity, and im...
Location
WRAIR Clinical Trials Center